Jorge Alvarez, MD
Pain Medicine · Langhorne, PANPI 1720396138
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,340 of the $8,223 with a category attached, or 77.1%. 13 manufacturers reported payments, led by Nevro Corp. at 40.8% of the total.
Across 154 payments — averaging $53.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$3K
- Medtronic$3K
- Stryker$900
- Globus Medical$525
- Si-bone, Inc.$234
- Gilead$122
- plus $294 from 7 others
What the payments were for
- Travel & lodging$1,88323%
- Food & beverage$6,34077%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 103 | $3,355 |
| Medtronic | 24 | $2,792 |
| Stryker | 3 | $900 |
| Globus Medical | 10 | $525 |
| Si-bone, Inc. | 2 | $234 |
| Gilead | 1 | $122 |
| Boston Scientific | 3 | $79 |
| AstraZeneca | 1 | $75 |
| Vertex | 1 | $53 |
| Merck | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Avanos Medical | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,219
- Senza$915
- Omnia$843
- OPTABLATE$759
- mild Device Kit$759
- INCEPTIV$754
- VANTA ADAPTIVESTIM$145
- INTELLIS ADAPTIVESTIM$138
- SPINEJACK$128
- Truvada$122
How this compares
$8,223 in reported general payments places this provider in the 85th percentile of 294 pain medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 46 | $31,673 |
| MovantikNaloxegol Oxalate | 18 | $7,089 |
| Celecoxib | 171 | $7,045 |
| Tramadol Hcl ErTramadol Hcl | 105 | $6,794 |
| Oxycodone Hcl | 294 | $5,362 |
| Lidocaine | 42 | $5,026 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 208 | $4,485 |
| Gabapentin | 214 | $2,753 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 111 | $2,484 |
| Diclofenac Sodium | 46 | $2,205 |
| Tramadol Hcl | 119 | $2,017 |
| Morphine Sulfate ErMorphine Sulfate | 59 | $1,957 |
| Pregabalin | 91 | $1,623 |
| Duloxetine Hcl | 53 | $1,091 |
| Nortriptyline Hcl | 75 | $1,053 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Langhorne
- Oleksiy LelyanovLanghorne$6K
- Peter PryzbylkowskiPhiladelphia$506K
- Yeshvant NavalgundGreensburg$388K
- Jack SmithWilliamsport$324K
- Sanjay GuptaBala Cynwyd$241K
- Vwaire OrhurhuWilliamsport$191K
- Philip KimBryn Mawr$128K
- Ajay WasanPittsburgh$66K
- Sanjay ShahSpring House$64K
- Soon JungAllentown$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.